A mini review of studies that include the therapeutic role of Chloroquine and Hydroxychloroquine in coronavirus disease-19 (COVID-19) Una mini revisión de estudios que incluyen el papel terapéutico de la cloroquina y la hidroxicloroquina en la enfermedad por coronavirus-19 (COVID-19)

Contenido principal del artículo

Ghdi Al msaoudi
Jumana Sako
Maha Alzahrani
Yosra Al-Hindi

Resumen

COVID-19 (Coronavirus Disease-2019) is now considered a public health
emergency of that concerns the whole globe. Despite it is still not approved, the use of aminoquinoline drugs such as chloroquine and hydroxychloroquine are now in increasing, especially with the pandemic of coronavirus disease 2019 (COVID-19). This mini review highlights the main information's gathered of using the therapeutic purpose of both these medications in the extraordinary situation of coronavirus disease -19.

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Sección
Artículos de COVID 19
Biografía del autor/a

Ghdi Al msaoudi, Umm Al-Qura University, Makkah, Saudi Arabia.

Pharm D candidate, Faculty of pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. 

Jumana Sako, Umm Al-Qura University, Makkah, Saudi Arabia.

Pharm D candidate, Faculty of pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. 

Maha Alzahrani, Faculty of pharmacy, Ibn-Sina National College, Jeddah, Saudi Arabia.

Pharm D candidate, Faculty of pharmacy, Ibn-Sina National College, Jeddah, Saudi Arabia. 
 

Yosra Al-Hindi, Umm Al-Qura University, Makkah, Saudi Arabia

Assistant Professor, Faculty of pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. 

Citas

Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020; 57:279-283. https://doi.org/10.1016/j.jcrc.2020.03.005

Borba MG, Val FF, Sampaio VS, Alexandre MA, Melo GC, Brito M, et al. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA network open. 2020; 3(4):1-14.DOI: 10.1001/jamanetworkopen.2020.8857

Tang D, Li J, Zhang R, Kang R, Klionsky DJ. Chloroquine in fighting COVID-19: good, bad, or both?. Autophagy. 2020; 25:1-3. https://doi.org/10.1080/15548627.2020.1796014

Singh AK, Singh A, Singh R, Misra A. Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis. Diabetes Metab Syndr. 2020; 14(4):589-596. https://doi.org/10.1016/j.dsx.2020.05.017

Bishara D, Kalafatis C, Taylor D. Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents. Ther Adv Psychopharmacol. 2020;10:1-15. DOI: 10.1177/ 2045125320935306

Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020; 55(3):1-2. https://doi.org/10.1016/j.ijantimicag.2020.105923

Das S, Bhowmick S, Tiwari S, Sen S. An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19). Clin Drug Investig. 2020; 1-11. https://doi.org/10.1007/s40261-020-00927-1

Jankelson L, Karam G, Becker ML, Chinitz LA, Tsai MC. QT prolongation, torsades de pointes and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: a systematic review. Heart Rhythm. 2020; 17(9):1472-1479.

https://doi.org/10.1016/j.hrthm.2020.05.008

Patil VM, Singhal S, Masand N. A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials. Life Sciences. 2020;117775. https://doi.org/10.1016/j.lfs.2020.117775

Prayuenyong, P, Kasbekar, AV, Baguley, DM. Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review. Front Public Health. 2020; 8:1-6. DOI:10.3389/fpubh.2020.00252

Sarma P, Kaur H, Kumar H, Mahendru D, Avti P, Bhattacharyya A,et al. Virological and clinical cure in COVID 19 patients treated with hydroxychloroquine: a systematic review and meta-analysis. J Med Virol. 2020;92(7):776–785. DOI: 10.1002/jmv.25898

Shah S, Das S, Jain A, Misra DP, Negi VS. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease 19 (COVID19). Int J Rheum Dis. 2020; 23(5):613-619. DOI: 10.1111/1756-185X.13842

Ji LN, Chao S, Wang YJ, Li XJ, Mu XD, Lin MG, et al. Clinical features of pediatric patients with COVID-19: a report of two-family cluster cases. World Journal of Pediatrics. 2020;16:267–270. https://doi.org/10.1007/s12519-020-00356-2

Tripathy S, Dassarma B, Roy S, Chabalala H, Matsabisa MG. A review on possible modes of actions of Chloroquine/Hydroxychloroquine: Repurposing against SAR-COV-2 (COVID 19) pandemic. Int J Antimicrob Agents. 2020; 56(2):1-7. https://doi.org/10.1016/j.ijantimicag.2020.106028